HutchIDSciences

Dr. Larry Corey and Dr. Pavitra Roychoudhury are quoted and @jbloom_lab, @trvrb, and @nextstrain are referenced.👇 COVID-19 experts answer questions about Omicron — and where the variant may have come from geekwire.com/2021/covid-19-… via @GeekWire

In this paper, bit.ly/3LnDLAB, we enrolled pre- and post-CAR-T cell therapy patients receiving SARS-CoV-2 vax. Humoral response poor pre-CAR-T, although T-cell responses were better and may recover after CAR-T infusion. Repeat vaccination post-CAR-T clearly important.

Join us for the ICHS poster walk with interesting discussions led by @PergamIC #ICHS2022

Link to DUOX1 and H2O2 production increases risk of fungal infections as well. #ICHS2022

Studying a rare disease provides insight into mechanisms of immune control - Dectin mutations block TNF production and increase Cocci and Aspergillosis risk by Steve Holland #ICHS2022

#ICHS2022 @GRThompsonMD

By day, by night - Basel is the place for an amazing meeting - strengthening bonds, building new collaborations and learning from the best TxID speakers #ICHS2022

Don't forget to join the Poster Walk with Dr. Robin Avery and Dr. Steven Pergam @pergamic at 10-10:30 during the Coffee Break - where we hear the authors of the top posters discuss their exciting new research #posterwalk #ICHS2022

Yes - we can - great start today @ichs2022, President Mike Recher and myself deeply honored by the talks from patient advocates and the expert clinician scientists Annelies Zinkernagel, Josh Milner, and Jay Fishman

The 3rd Opening Plenary will be given by Dr. Jay Fishman Director of the Transplant Infectious Diseases & Compromised Host Program @mgh_id, will update us on "Infection and Immunity: The Challenge of Safe Xenotransplantation" #ICHS2022

Great work by @MadyHeldman and team exploring HHV-6 integration site in patients with heme malignancies. @HutchIDScience Chromosome-Specific Human Herpesvirus 6 Integration and Hematologic Malignancies | Journal of Virology journals.asm.org/doi/10.1128/jv…

@HannahImlay’s papers highlighted in the most impactful transplant ID papers @ #ATCBoston2022. @AST_IDCOP @UofUMedicine @HutchIDScience @UWIDFellowship

We love to see it!! 👏

Honored to be part of this important perspective on equitable access to COVID therapeutics, led by @JayCdoesID. @IDSAInfo @HutchIDScience @uwmnewsroom sciencedirect.com/science/articl…

📢ICYMI 🚨Fantastic opportunity for an APP to join our ID group @fredhutch in Seattle! 🦠💊🌎 Apply here 👉careers-fhcrc.icims.com/jobs/22305/adv…

📢🚨Fantastic opportunity for an APP to join our ID group @fredhutch in Seattle! Apply here 👉careers-fhcrc.icims.com/jobs/22305/adv…

🚨📢 Join our ID Faculty! New clinical scholar position open @fredhutch in Seattle! It's an amazing opportunity to join a dynamic group of Tx/Cancer ID experts in a fantastic academic environment. Apply here 👉apply.interfolio.com/105631

Proud to have represented @fredhutch and @NCICancer at #Tandem22! Inspired by presentations by friends and colleagues leading the field, from mice models by @simone_minnie, to clinical practice by @JoshuaHillMD, to guidelines by @michyong2. It’s the @ASTCT full circle!

Dr. Larry Corey, professor (Allergy and Infectious Diseases) wrote “Learning to live with COVID-19” for the @seattletimes and “Forget Boosters—Will You Need an Annual Covid Shot?” in the @SeattleMet seattlemet.com/health-and-wel…

Drs. Seth Cohen and Joshua Schiffer (Allergy and Infectious Diseases) are quoted in @seattletimes 👇 seattletimes.com/seattle-news/h…

@zamora_danniel @PergamIC @NIAIDFunding @fredhutch Congratulations!! 👏